mRNA Vaccines Against Bacteria Pathogens

Modality

mRNA Vaccines Against Bacteria Pathogens

In addition to viral antigens, disease-causing bacteria can also cause infections. For example, tuberculosis (TB), infected by Mycobacterium tuberculosis, has long provided the leading cause of death worldwide. However, only few bacterial and parasite antigens have been used in clinical trials for mRNA vaccines, and many of them are still in the preclinical stage.

The use of mRNA vaccines in the future for the prevention of bacterial infections will require further optimization, including the selection of key antigens and antigenic epitopes, periodic injections of different target antigens, and even the direct addition of adjuvanted passive immune compositions.

Yaohai Bio-Pharma Offers One-Stop Solution for RNA

Catalog RNA Products

Catalog mRNA Products
Catalog saRNA Products
Catalog circRNA Products

Custom RNA Synthesis

Custom mRNA Synthesis
Custom saRNA Synthesis
Custom circRNA Synthesis

mRNA CDMO Services

Process Development
GMP Manufacturing
Aseptic Fill and Finish
Analysis and Testing

Custom Deliverables

Grade	Deliverables	Specification	Applications
non-GMP	Drug Substance, mRNA	0.1~10 mg (mRNA)	Preclinical research such as cell transfection, Analytical method development, Pre-stability studies, Formulation development
	Drug Product, LNP-mRNA
GMP, Sterility	Drug Substance, mRNA	10 mg~70 g	Investigational new drug (IND), Clinical trial authorisation (CTA), Clinical trial supply, Biologic license application (BLA), Commercial supply
	Drug Product, LNP-mRNA	5000 vials or pre-filled syringes/ cartridges

All Categories

mRNA Vaccines Against Bacteria Pathogens

Modality